Cord Blood America, Inc. (CBAI) Posts Q3 Financial Results
Cord Blood America, through its wholly owned subsidiary CorCell Companies, Inc., collects, tests, and preserves umbilical cord blood for potential use in future stem cell therapy. The company Thursday reported its third-quarter financial results for the three months ended September 30, 2013. Total revenue decreased 2 percent to approximately $1.49 million from revenue of $1.51 million in the same period of 2012. Recurring revenue increased approximately 8 percent to $684,374 from the year ago period. Cash provided by operations increased 247 percent to $333,034 for the nine months ended September 30, 2013, as compared to a loss of $227,064 in…